Literature DB >> 12543723

The pathogenesis of filarial lymphedema: is it the worm or is it the host?

Patrick J Lammie1, Karen T Cuenco, George A Punkosdy.   

Abstract

Our understanding of the pathogenesis of filarial lymphedema, although evolving, is still limited. Recurrent bacterial infections play a major role in the progression of lymphedema to elephantiasis, but the host and parasite factors that trigger disease development are not known. Field studies in Haiti show that lymphedema and host responses to parasite antigens cluster in families, consistent with the hypothesis that host genes influence lymphedema susceptibility. The recent recognition that filarial parasites harbor the endosymbiotic bacteria, Wolbachia, also raises questions about the potential contribution of the inflammatory response to Wolbachia antigens to lymphedema development. In this review, we discuss potential risk factors for lymphedema and try to integrate these in a model of pathogenesis.

Entities:  

Mesh:

Year:  2002        PMID: 12543723     DOI: 10.1111/j.1749-6632.2002.tb04874.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Effects of gamma radiation on Brugia malayi infective larvae and their intracellular Wolbachia bacteria.

Authors:  R Rao; H Moussa; R P Vanderwaal; E Sampson; L J Atkinson; G J Weil
Journal:  Parasitol Res       Date:  2005-07-05       Impact factor: 2.289

2.  Characterization of antibody responses to Wolbachia surface protein in humans with lymphatic filariasis.

Authors:  George A Punkosdy; David G Addiss; Patrick J Lammie
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

3.  Molecular identification of Wolbachia from the filarial nematode Mansonella perstans.

Authors:  Paul B Keiser; Yaya Coulibaly; Joseph Kubofcik; Abdallah A Diallo; Amy D Klion; Sekou F Traoré; Thomas B Nutman
Journal:  Mol Biochem Parasitol       Date:  2008-05-02       Impact factor: 1.759

4.  Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.

Authors:  Daniel J Tisch; Neal D E Alexander; Benson Kiniboro; Henry Dagoro; Peter M Siba; Moses J Bockarie; Michael P Alpers; James W Kazura
Journal:  PLoS Negl Trop Dis       Date:  2011-07-12

5.  Lymphatic filariasis: a method to identify subclinical lower limb change in PNG adolescents.

Authors:  Susan Gordon; Wayne Melrose; Jeffrey Warner; Petra Buttner; Leigh Ward
Journal:  PLoS Negl Trop Dis       Date:  2011-07-19

6.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

7.  Elimination of lymphatic filariasis as a public health problem in Niue under PacELF, 1999-2016.

Authors:  Catherine N Carlingford; Wayne Melrose; Grizelda Mokoia; Patricia M Graves; Kazuyo Ichimori; Corinne Capuano; Sung Hye Kim; Padmasiri Aratchige; Manila Nosa
Journal:  Trop Med Health       Date:  2019-03-15

Review 8.  The History of Bancroftian Lymphatic Filariasis in Australasia and Oceania: Is There a Threat of Re-Occurrence in Mainland Australia?

Authors:  Catherine A Gordon; Malcolm K Jones; Donald P McManus
Journal:  Trop Med Infect Dis       Date:  2018-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.